Literature DB >> 21740415

Use of inotropes and vasopressor agents in critically ill patients.

Mansoor N Bangash1, Ming-Li Kong, Rupert M Pearse.   

Abstract

Inotropes and vasopressors are biologically and clinically important compounds that originate from different pharmacological groups and act at some of the most fundamental receptor and signal transduction systems in the body. More than 20 such agents are in common clinical use, yet few reviews of their pharmacology exist outside of physiology and pharmacology textbooks. Despite widespread use in critically ill patients, understanding of the clinical effects of these drugs in pathological states is poor. The purpose of this article is to describe the pharmacology and clinical applications of inotropic and vasopressor agents in critically ill patients.
© 2011 The Authors. British Journal of Pharmacology © 2011 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21740415      PMCID: PMC3413841          DOI: 10.1111/j.1476-5381.2011.01588.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  236 in total

1.  Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group.

Authors:  R Bellomo; M Chapman; S Finfer; K Hickling; J Myburgh
Journal:  Lancet       Date:  2000 Dec 23-30       Impact factor: 79.321

2.  Effects of prolactin and metoclopramide on macrophage cytokine gene expression in late sepsis.

Authors:  X H Zhu; R Zellweger; M W Wichmann; A Ayala; I H Chaudry
Journal:  Cytokine       Date:  1997-06       Impact factor: 3.861

Review 3.  Catecholamine metabolism: basic aspects and clinical significance.

Authors:  I J Kopin
Journal:  Pharmacol Rev       Date:  1985-12       Impact factor: 25.468

4.  Correlation of the directly observed responses of mesenteric vessles of the rat to nerve stimulation and noradrenaline with the distribution of adrenergic nerves.

Authors:  J B Furness; J M Marshall
Journal:  J Physiol       Date:  1974-05       Impact factor: 5.182

5.  Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.

Authors:  Florian Simon; Ricardo Giudici; Angelika Scheuerle; Michael Gröger; Pierre Asfar; Josef A Vogt; Ulrich Wachter; Franz Ploner; Michael Georgieff; Peter Möller; Régent Laporte; Peter Radermacher; Enrico Calzia; Balázs Hauser
Journal:  Crit Care       Date:  2009-07-10       Impact factor: 9.097

6.  Selective mobilization of cytotoxic leukocytes by epinephrine.

Authors:  Stoyan Dimitrov; Tanja Lange; Jan Born
Journal:  J Immunol       Date:  2009-11-30       Impact factor: 5.422

7.  Beta-adrenergic receptor-dependent and -independent stimulation of adenylate cyclase is impaired during severe sepsis in humans.

Authors:  G Bernardin; A D Strosberg; A Bernard; M Mattei; S Marullo
Journal:  Intensive Care Med       Date:  1998-12       Impact factor: 17.440

8.  Epinephrine plasma metabolic clearance rates and physiologic thresholds for metabolic and hemodynamic actions in man.

Authors:  W E Clutter; D M Bier; S D Shah; P E Cryer
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

Review 9.  The microcirculation is the motor of sepsis.

Authors:  Can Ince
Journal:  Crit Care       Date:  2005-08-25       Impact factor: 9.097

10.  Vasopressin impairs brain, heart and kidney perfusion: an experimental study in pigs after transient myocardial ischemia.

Authors:  Stig Müller; Ole-Jakob How; Stig Eggen Hermansen; Thor Allan Stenberg; Georg Sager; Truls Myrmel
Journal:  Crit Care       Date:  2008-02-21       Impact factor: 9.097

View more
  25 in total

1.  Inotropes and vasopressors: more than haemodynamics!

Authors:  Hendrik Bracht; Enrico Calzia; Michael Georgieff; Joel Singer; Peter Radermacher; James A Russell
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 2.  Vasopressors in obstetric anesthesia: A current perspective.

Authors:  Deb Sanjay Nag; Devi Prasad Samaddar; Abhishek Chatterjee; Himanshu Kumar; Ankur Dembla
Journal:  World J Clin Cases       Date:  2015-01-16       Impact factor: 1.337

3.  Critical biomechanical and clinical insights concerning tissue protection when positioning patients in the operating room: A scoping review.

Authors:  Amit Gefen; Sue Creehan; Joyce Black
Journal:  Int Wound J       Date:  2020-06-04       Impact factor: 3.315

Review 4.  Pathophysiological mechanisms of catecholamine and cocaine-mediated cardiotoxicity.

Authors:  Lucas Liaudet; Belinda Calderari; Pal Pacher
Journal:  Heart Fail Rev       Date:  2014-11       Impact factor: 4.214

Review 5.  [Catecholamines: pro and contra].

Authors:  R Riessen; O Tschritter; U Janssens; M Haap
Journal:  Med Klin Intensivmed Notfmed       Date:  2015-03-25       Impact factor: 0.840

6.  Vasopressors in shock: too early to move away from catecholamines?

Authors:  D De Backer; S Scolletta
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

7.  Concurrent Use of Calcium Chloride and Arginine Vasopressin Infusions in Pediatric Patients with Acute Cardiocirculatory Failure.

Authors:  Karan B Karki; Jeffrey A Towbin; Camden Harrell; James Tansey; Joseph Krebs; William Bigelow; Arun Saini; Sachin D Tadphale
Journal:  Pediatr Cardiol       Date:  2019-05-07       Impact factor: 1.655

8.  Why Not Life and Limb? Vasopressor Use in Intensive Care Unit Patients the Cause of Acute Limb Ischemia.

Authors:  Anastassia Newbury; Katharine D Harper; Arianna Trionfo; Frederick V Ramsey; Joseph J Thoder
Journal:  Hand (N Y)       Date:  2018-08-03

Review 9.  The autonomic nervous system in septic shock and its role as a future therapeutic target: a narrative review.

Authors:  Marta Carrara; Manuela Ferrario; Bernardo Bollen Pinto; Antoine Herpain
Journal:  Ann Intensive Care       Date:  2021-05-17       Impact factor: 6.925

10.  Development and validation of parsimonious algorithms to classify acute respiratory distress syndrome phenotypes: a secondary analysis of randomised controlled trials.

Authors:  Pratik Sinha; Kevin L Delucchi; Daniel F McAuley; Cecilia M O'Kane; Michael A Matthay; Carolyn S Calfee
Journal:  Lancet Respir Med       Date:  2020-01-13       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.